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ABSTRACT 
Objective: Propranolol Hydrochloride (PHCL) is used for the treatment of hypertension and angina pectoris; however it has two major problems; 
short biological half‐life and low bioavailability, so the aim of the present work was to develop PHCL mucoadhesive microsphere to prolong the 
residence time at the absorption site, therefore, increase the bioavailability. 
Methods: PHCL microspheres were prepared by ionotropic gelation method using nature polymers. Factorial design (33) was used to develop PHCL 
mucoadhesive microspheres, the independent factors used were polymer type (Sodium carboxymethyl cellulose (Na CMC), and Hydroxyl propyl 
methyl cellulose (HPMC), Carpobol 940), cross‐linking type (calcium chloride, zinc chloride and barium chloride) and the concentration of Chitosan 
(0.5, 1, 1.5 %w/v). The developed microspheres were physicochemical characterized. The selected formula was selected for mucoadhesive test and 
in vivo study on human volunteers.  
Results: The results revealed that the PHCL mucoadhesive microspheres have good flowability, the mean particle sizes ranged from 541 to 815 µm 
and the entrapment efficiency ranged from 35.6% to 69.53%. The selected PHCL microspheres showed spherical particles with a rough surface and 
exhibited a slow release over 8h. The pharmacokinetic data of selected PHCL microspheres showed prolonged Tmax, decreased Cmax and AUC0–∞ value 
of 926.21±40.74ng. h/ml indicating improved relative bioavailability by144.93% compared with marketed tablets. 
Conclusion: PHCL microspheres were successfully prepared by ionic gelatin method that retards the release and enhances the oral bioavailability.  
Keywords: Propranolol HCL, Microspheres, Ionic gelation method, Chitosan, Relative bioavailability 
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INTRODUCTION 
PHCL is a non‐selective β‐adrenergic blocking agent used in the 
treatment of hypertension, angina pectoris and many other 
cardiovascular disorders [1]. A drug with short elimination half‐life 
are most suitable for prolonged release dosage design, and it can be 
achieved by microspheres formulation which provides a larger 
surface area. It’s also limiting fluctuate within a therapeutic range, 
reduction in side effects and dose frequency, hence improved patient 
compliance [2]. Conventional form available is administered orally 
in doses of 40 mg to 160 mg twice a day [3], but due to raising 
problems with the conventional tablet resulting in fluctuations of 
drug plasma levels and also the drug has short biological half‐life (3‐
4 h) and first pass metabolism makes it a potential candidate for the 
design of sustained release dosage forms [4]. 
Alginates, an anionic, biodegradable and biocompatible natural 
polymer which are naturally occurring substances, found in brown 
algae have received much interest as a vehicle for sustained drug 
delivery [5]. Alginates can form hydrogels in the presence of divalent 
cations like Ca2+through ionically cross‐linked by the addition of 
divalent cations in aqueous solution[6]. Chemical and/or physical 
cross‐linking of hydrophilic polymers are typical approaches to form 
hydrogels, and their physicochemical properties are highly 
dependent on the cross‐linking type and cross‐linking density, in 
addition to the molecular weight and chemical composition of the 
polymers. Here, we summarize various approaches to cross‐link 
alginate chains to prepare gels, and how these approaches alter the 
hydrogel properties relevant to biomedical applications. 
Chitosan, a polysaccharide derived from chitin by alkaline 
deacetylation, has been used to strengthen alginate microspheres 
based on the electrostatic interaction between carboxylate groups in 
alginate and ammonium groups in Chitosan. Chitosan–alginate 
complex erode slowly in phosphate buffer, and this behavior leads to 
inhibition of the initial release of drugs[7]. In this work, nature of the 
biodegradable polymers (Chitosan, Na CMC, Carpobol 940, HPMC 
and Sodium alginate) were used to prepare mucoadhesive 
microspheres.  
MATERIALS AND METHODS 
Materials 
PHCL was generously gifted from Astra‐Zeneca, Egypt. Sodium 
alginate, NaCMC, Carpobol 940 and HPMC (Sigma Chemical Co., St. 
Louis). Chitosan: Group corneal laboratories company. Calcium 
chloride, zinc chloride, barium chloride, and glacial acetic acid. All 
other chemicals were of analytical grade. 
Method 
Experimental design 
Propranolol loaded microspheres were prepared using a (3³) full 
factorial design. The design was applied to investigate the effect of 
the independent variables; chitosan concentration (X1), the type of 
crosslinking agent (X2), and polymer type (X3) on the 
physicochemical properties of the prepared microspheres (table 1). 
Preparation of PHCL loaded microspheres 
Drug‐loaded microspheres were prepared using a modified ionic 
gelation method [8]. A 5% (w/v) sodium alginate solution was 
prepared in distilled water by properly mixing with slight 
heating. This concentration of sodium alginate remains constant 
in all formulations. To the alginate solution, an accurately 
weighed (100 mg) propranolol was dispersed and mixed. A 3% 
w/v aqueous solution of NaCMC, Carpobol 940 or HPMC was 
then added and uniformly mixed under magnetic stirrer to form 
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a smooth, viscous dispersion. The previous solution was then 
added dropwise using a hypodermic syringe (21 gauge needle) 
to the continuously stirred glacial acetic acid solution of chitosan 
and the divalent cross‐linking agent. The microspheres were 
cured for 15 min and then collected, washed twice with acetone, 
and dried at room temperature (25±0.5 °C) for 24hours (fig. 1). 
The matrix of the 27 formulations design including responses 
such as yield percentage %, particle size (µm), entrapment 
efficiency, and percentage drug released after 8 h is shown in 
table 2. 
 
Table 1: Composition of different coded values in 33 full factorial designs. 
Independent variable Code value -1 0+1 
Chitosan concentration w/v % (X1) 0.5 1 1.5 
Type of cross‐linking agent (X2) Calcium chloride barium chloride zinc chloride 
Polymer type (X3) *HPMC *Na CMC Carpobol 940 
*Na CMC (Sodium carboxymethyl cellulose), HPMC (Hydroxyl propyl methyl cellulose)  
 
Characterization of the prepared microspheres 
Percentage yield  
The percentage yield was determined for the dried microspheres 
using the following equation[9]: 
%Yield = 
(Actual weight of microsphere/
Total weight of excipient and drug) × 100 (Equation1) 
Micrometric properties evaluation 
Particle sizes analysis 
The particle size of the Propranolol loaded microspheres was 
determined by optical microscopy fitted with a stage calibrated 
micrometer. About 50 particles from each formulation were 
examined, and the mean diameter was calculated.  
Flow properties 
Both bulk density and tapped density were determined. A quantity 
of 5 g of powder from each formula was introduced in 10 ml 
measuring cylinder. After the initial volume was observed, the 
cylinder was allowed to fall onto a hard surface. The tapping was 
continued until no further change in volume was observed [10].  
The bulk density of the microspheres was calculated by using the 
following equation:  
bulk density = weight of powder volume of packing⁄  (Equation2) 
The tapped density was calculated by using the following equation:  
bulk density = weight of powder tapped volume of packing⁄  
(Equation3) 
Hausner ratio and Carr’s index were estimated using the below‐
mentioned equations; 
𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯 𝑯𝑯𝑯𝑯𝒓𝒓𝒓𝒓𝒓𝒓 = (𝒓𝒓𝑯𝑯𝒕𝒕𝒕𝒕𝑯𝑯𝒕𝒕 𝒕𝒕𝑯𝑯𝑯𝑯𝑯𝑯𝒓𝒓𝒓𝒓𝒅𝒅/𝒃𝒃𝑯𝑯𝒃𝒃𝒃𝒃 𝒕𝒕𝑯𝑯𝑯𝑯𝑯𝑯𝒓𝒓𝒓𝒓𝒅𝒅) (Equation4) 
Carr’s inde = (tapped density − bulk density)/tapped density ×
 100 (Equation5) 
The angle of repose of different formulations was measured 
according to fixed funnel flow method using the following 
equation[4].  
θ =  tan− 1 height/radius (Equation6) 
Drug entrapment efficiency 
The prepared drug‐loaded microspheres were checked for their 
drug content. Accurately weighed 100 mg of the dried microspheres 
were powdered and dissolved in 100 ml phosphate buffer (pH 7.4). 
The solution was kept overnight and then filtered using 0.45 µm 
cellulose acetate syringe filter. The filtered solution was analyzed 
spectrophotometrically at 290 nm using UV‐visible 
Spectrophotometer (UV‐1800 Shimadzu, Japan). The entrapment 
efficiency was determined [11] using the following equation:  
Drug entrapment (%) = 
(actual drug concentration/theoretical drug concentration)  ×  100 (Eqe… 7) 
In vitro drug release 
The in vitro release was determined in 900 ml 0.1N HCL (pH 1.2) for 
2 h and then in 900 ml phosphate buffer (pH 7.4) using USP 
dissolution tester (apparatus I) at 50 rpm and a temperature of 
37±0.5 oC. Capsules filled with microspheres containing an 
equivalent to 40 mg PHCL were tested, samples were taken over a 
period of 8 h and analyzed spectrophotometry at 290 nm [12]. 
Kinetic analysis of the release data 
In order to analyzes the release mechanism, the obtained in vitro 
release data was fitted to various mathematical models such as 
zero order, First order, Higuchi diffusion, and Korsmeyer‐Peppas 
model [13]. 
In vitro muco adhesivity 
The mucoadhesive properties of the microspheres were evaluated 
by in vitro wash‐off test [14]. A 1x1 cm piece of rat stomach mucosa 
was tied onto a glass slide (3‐inch by 1‐inch) using thread. 
Microspheres were spread (∽50) onto the wet, rinsed, tissue 
specimen, and the prepared slide was hung onto one of the groves of 
a USP tablet disintegrating test apparatus. The disintegrating test 
apparatus was operated such that the tissue specimen was given 
regular up and down movements in a beaker containing the 
simulated gastric fluid (pH 1.2). At hourly intervals up to 8hours, the 
number of microspheres still adhering onto the tissue was counted. 
Percent mucoadhesion was given by the following equation:  
% Mucoadhesion=(no of microspheres remains/no of applied 
microspheres) X100 (Equation 8) 
Fourier transform infra-red spectroscopy (FTIR) 
FTIR of the selected best formula was studied to check possible 
drug‐polymer incompatibilities. The FTIR spectra for propranolol, 
various polymers, and drug‐loaded microspheres (F20) were 
obtained at room temperature in KBr pellets using FTIR 
spectrophotometer (Alpha‐Bruker, Germany) in the transmission 
mode range 500‐4000 cm1 [15]. 
Scanning electron microsphere and morphological studies 
The surface morphology of the microspheres (F20) was studied 
using scanning electron microscopy (SEM; S‐4100, Hitachi, Japan). 
The samples were prepared by lightly sprinkling the microspheres 
powder on a double side adhesive tape which already shucked to on 
aluminum stubs. The stubs were then placed into fine coat ion 
sputter for gold coating. Finally, samples were randomly scanned for 
particle size and surface morphology [14]. 
In vivo study 
A double‐blind, randomized, cross‐over study was carried out to 
compare the pharmacokinetic parameters of PHCL from the chosen 
microsphere formulation (F20) and the market product, Inderal ®, 
tablet (AstraZeneca, Egypt). A single dose containing an equivalent 
amount to 40 mg of PHCL was given to the volunteers, who were 
fastened overnight. The washout period was one week. The protocol 
of the study was conducted according to the requirements of the 
ethical committee of the Faculty of pharmacy, Beni‐Suef University, 
Egypt. 
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Six healthy Egyptian male volunteers aged between 25 and 35 y 
(median weight: 75±6.5 kg and median height: 173±6.9 cm) were 
chosen. The health status was confirmed by complete physical 
examination and laboratory analysis. No drugs were allowed to be 
taken one week before and during the study. 
Sample collection 
Blood samples (5 ml) were collected in heparin rinsed tubes at 
different time intervals: 0.5, 1, 1.5, 2, 4, 6, 10, 12, 18 and 24 h after 
oral administration. The samples were then centrifuged at 3000 rpm 
and the plasma was stored at‐20 ˚C.  
Chromatographic conditions 
A modified method [16] was conducted for the analysis of PHCL in 
plasma using high‐performance liquid chromatography (HPLC; 
Shimadzu, Koyoto, Japan). The mobile phase consisted of 
acetonitrile: aqueous acetic acid (1%containing 0.2% 
trimethylamine) (35:65, v/v), the pH adjusted at 3.6 with 0.1 N 
sulphoric acid. The flow rate was 1.5 ml min‐1, and the fluorescence 
detector was adjusted at an excitation wavelength of 230 nm and an 
emission wavelength of 340 nm.  
Plasma analysis 
1 ml of acetonitrile was added to 200 µl of plasma followed by 
vortex shaking and centrifugation at 2000 rpm. The clear 
supernatant was evaporated under a stream of nitrogen at 50‐60 ˚C 
until dryness. The residue was dissolved in 100 µl of methanol and 
then injected into the HPLC for PHCL quantitation. 
Pharmacokinetic study 
The pharmacokinetic parameters from plasma data following the 
oral administration of the two formulae were estimated using 
WinNonlin, version 1.5 (Scientific Consulting, Inc., Cary, NCT). 
Maximum plasma concentration (Cmax), time to reach Cmax (Tmax), 
elimination half‐life (t½) and area under the plasma concentration‐
time curve (AUC) were determined. The level of absorption from 
selected microspheres formulation relative to the reference was 
calculated as the relative bioavailability by using the equation [17]: 
The relative bioavailability =  (AUC test/AUC reference X100) 
(Equation 9) 
T‐test has been used to verify the differences in drug bioavailability 
between the selected formula and the reference. The level of 
statistical significance was chosen at p<0.05. 
Statistical analysis 
Statistical analysis was performed using three‐way analysis of 
variance (ANOVA) test followed by Tukey‐Kramer multiple 
comparisons test, by applying statistical package for the social 
sciences (SPSS; version 19.0) computer software program (SPSS Inc., 
Chicago, IL, USA), with the value of p<0.05 considered statistically 
significant. 
RESULTS AND DISCUSSION 
Preparation and characterization of PHCL loaded microspheres 
The chosen concentration of the alginate, polymers, and the cross‐
linking agent were optimized by trial and error method. Ramalingam 
Nethaji et al. formulated PHCL microspheres by ionic gelation, PHCL 
were mixed with NaCMC and different ratios of sodium alginate, 
using calcium chloride 5% as cross‐linking agent [2]. Nazia Khanam 
et al. formulated PHCL microspheres by ionic gelation method using 
various ratios of sodium alginate and Eudragit RS100 and using 
calcium chloride 5% as cross‐linking agent [8].  
In this research, PHCL microspheres were prepared using three 
different divalent cations, calcium, barium and zinc as cross‐linking 
agents, with chitosan added to them. Chemical cross‐linking of 
hydrophilic polymers is a typical approach to form microspheres, 
and the physicochemical properties of the prepared microspheres 
are highly dependent on the cross‐linking type, as well as the 
molecular weight and chemical composition of the used polymers. 
fig. 1, illustrated an example of the prepared microspheres before 
and after the drying process. 
 
 
Fig. 1: The prepared microspheres before drying (a) and after 
drying (b) 
 
The percentage yield of PHCL microspheres was found to range from 
46% to 65%. There was no significant difference at p<0.05 in the 
percentage yield between the prepared formulations and hence no 
effect of the independent variables on this parameter.  
The particle sizes of microspheres were illustrated in table 2 and 
ranged from 541 µm to 815 µm. Statistical analysis of the particle 
size data (table 4), showed that the variation of microspheres size 
may be attributed to the change in the co‐polymer type. There was a 
significant increase in the particle size of the PHCL spheres prepared 
with Na CMC. Regarding the type of cross‐linking agent, the use of 
calcium chloride resulted in a significant decrease in particle size. 
Calcium chloride is one of the most frequently used materials for 
alginate crosslinking. However, it could lead to rapid and poorly 
controlled gelation due to its high solubility in aqueous solutions and 
hence small size microspheres in comparison with other cross‐linking 
agents [18]. The increase in the size of the microspheres was obviously 
significant above 0.5% chitosan concentration which may be 
attributed to the increase in the viscosity of the gelation medium [19]. 
The bulk and tapped densities were measured to evaluate the 
packability of microspheres. Meanwhile, Hausner's ratio and Carr’s 
index give indication about flowability. Carr's index greater than 25 
indicating poor flowability and below15 indicating good flowability. 
All formulation exhibited Carr's index below 15 which is considered 
as an indication of good flow properties angle of repose ranged from 
26.65 to 34.95 as shown in table 3. 
The percentage drug entrapment efficiency of the prepared 
microspheres was found to be in the range of 35.6% to 69.53% as 
shown in table 2. The co‐polymers could be arranged according to 
their ability to encapsulate the drug in the following order: Carpobol 
940>HPMC>Na CMC (table 4). These results may be attributed to 
decreased diffusion of the drug from the microspheres by increased 
viscosity of the polymer used [20].  
The statistical analysis of the encapsulation efficiency data revealed 
that there was the insignificant effect on this parameter by the change 
of the type of cross‐linking agent as well as the increase in the 
concentration of chitosan (table 4). 
Regarding the drug release from the prepared microspheres, 
alginate is able to form complex with divalent ions like Zn+2, Ba+2, 
Ca+2 and the association is stronger with calcium than other ions 
[21]. The formulations containing Ca+2 showed a slower release of 
PHCL as calcium is more densely cross‐linked with alginate than 
Zn+2, Ba+2. This could be attributed to the increased interaction 
between Na+present in alginate and Ca+2, forming closer network 
which decreased the diffusion of drug outwards the alginate 
microspheres [15]. However, there was insignificant effect between 
the three cations and the concentration of chitosan on the total 
amount released after 8 h as shown in (fig. 2). 
Formulations containing Na CMC showed faster release of the drug 
than HPMC and Carpobol 940, which may be due to high swelling 
action and increased solubility of Na CMC in the dissolution medium 
that may lead to increase the transport of the drug outside the 
matrix [14]. 
Kharshoum et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 311-317 
 
314 
Table 2: 33 full factorial design of PHCL loaded microspheres with responses 
Formulation code X1 X2 
 




Percentage drug entrapment 
Efficiency (±SD) 
Percentage drug release 
after 8 h (±SD) 
M1 ‐1 ‐1 ‐1 64.01±0.17 560±0.05 63.80±0.20 83.14±0.02 
M2 ‐1 0 ‐1 52.21±0.11 630±0.14 59.30±0.50 85.25±0.03 
M3 ‐1 +1 ‐1 46.02±0.01 655±0.10 48.93±0.06 91±0.06 
M4 0 ‐1 ‐1 59.62±0.03 584±0.04 52.50±0.13 81.33±0.03 
M5 0 0 ‐1 61.15±0.17 659±0.08 48.90±0.30 90±0.05 
M6 0 +1 ‐1 62.41±0.05 701±0.05 50.00±0.26 96±0.03 
M7 +1 ‐1 ‐1 64.01±0.11 591±0.03 52.14±0.03 85.23±0.02 
M8 +1 0 ‐1 61.97±0.29 679±0.04 48.48±0.03 95.78±0.05 
M9 +1 +1 ‐1 62.55±0.47 720±0.07 40.6±0.09 88±0.05 
M10 ‐1 ‐1 0 55.36±0.27 640±0.04 50.83±0.04 90±0.02 
M11 ‐1 0 0 56.45±0.23 710±0.01 45.03±0.05 92.25±0.06 
M12 ‐1 +1 0 53.97±0.12 740±0.03 35.6±0.02 98.67±0.06 
M13 0 ‐1 0 50.21±0.23 735±0.06 37.84±0.02 95.33±0.04 
M14 0 0 0 52.88±0.24 780±0.08 38.96±0.03 91.2±0.02 
M15 0 +1 0 65.32±0.19 803±0.09 37.49±0.03 97.2±0.03 
M16 +1 ‐1 0 59.92±0.26 730±0.12 50.00±0.02 93.82±0.02 
M17 +1 0 0 58.1±0.18 780±0.06 45.90±0.03 95.78±0.03 
M18 +1 +1 0 53.45±0.20 815±0.02 45.50±0.02 94±0.09 
M19 ‐1 ‐1 +1 64.01±0.14 541±0.09 69.53±0.02 72.33±0.03 
M20 ‐1 0 +1 60.43±0.29 595±0.09 66.12±0.02 61.34±0.04 
M21 ‐1 +1 +1 48,09±0.05 602±0.07 59.42±0.03 79.93±0.03 
M22 0 ‐1 +1 56.29±0.22 590±0.06 57.25±0.03 80.43±0.03 
M23 0 0 +1 59.97±0.19 622±0.02 43.40±0.01 66.34±0.04 
M24 0 +1 +1 56.53±0.40 640±0.09 42.30±0.02 81.57±0.05 
M25 +1 ‐1 +1 64.28±0.27 612±0.12 65.80±0.02 79.89±0.04 
M26 +1 0 +1 55.37±0.09 685±0.04 54.50±0.02 81.09±0.05 
M27 +1 +1 +1 56.29±0.26 705±0.06 50.80±0.02 83.94±0.04 
*(mean±SD, n=3) 
 









Hausner's ratio Angle of repose 
M1 0.734±0.12 0.801±0.05 8.36 1.09 27.95±2.11 
M2 0.721±0.11 0.812±0.03 11.20 1.12 30.45±1.97 
M3 0.792±0.03 0.887±0.08 10. 71 1.13 29.36±3.01 
M4 0.751±0.09 0.850±0.10 11.64 1.13 31.75±2.67 
M5 0.742±0.79 0.866±0.09 14.34 1.16 33.84±1.18 
M6 0.722±0.11 0.852±0.08 15.25 1.18 34.95±3.64 
M7 0.733±0.13 0.821±0.12 10.71 1.12 29.46±2.54 
M8 0.698±0.21 0.800±0.09 12.75 1.14 31.82±3.17 
M9 0.870±0.06 0.997±0.13 12.73 1.14 26.81±2.58 
M10 0.725±0.03 0.789±0.04 8.11 1.08 23.52±1.77 
M11 0.756±0.11 0.862±0.06 12.29 1.14 27.92±3.05 
M12 0.820±0.15 0.932±0.08 12.01 1.13 33.61±2.66 
M13 0.744±0.13 0.825±0.13 9.81 1.10 27.51±1.45 
M14 0.724±0.17 0.867±0.11 16.49 1.19 35.76±4.21 
M15 0.755±0.07 0.888±0.06 14.97 1.17 33.99±1.79 
M16 0.734±0.12 0.845±0.03 13.13 1.15 26.98±1.98 
M17 0.777±0.25 0.856±0.11 9.22 1.10 27.85±2.47 
M18 0.754±0.09 0.844±0.05 10.66 1.11 29.40±1.69 
M19 0.775±0.13 0.850±0.08 8.8 1.09 28.10±2.07 
M20 0.740±0.05 0.821±0.06 9.86 1.10 26.65±1.21 
M21 0.735±0.14 0.833±0.03 11.76 1.13 30.78±1.58 
M22 0.723±0.05 0.802±0.11 9.85 1.10 27.33±3.66 
M23 0.775±0.12 0.887±0.12 12.62 1.14 32.43±2.90 
M24 0.730±0.08 0.845±0.09 13.60 1.15 33.25±1.55 
M25 0.744±0.09 0.821±0.07 9.37 1.10 28.71±4.22 
M26 0.740±0.13 0.823±0.06 9.82 1.11 27.99±3.62 
M27 0.723±0.12 0.845±0.13 13.37 1.16 27.31±2.08 
Each sample was analyzed in triplicate (n = 3) *mean±SD 
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Table 4: Statistical analysis for the effect of independent variables on the microspheres characteristics 
 Release%over 
6 h 
% Drug entrapment 
efficiency 
Particle size Percentage yield% Factors Independent variables 
88.31±1.74(ac) 51.62±2.22 642.11±18.34(ab) 59.32±2.04 HPMC Polymer type 
94.25±0.93(bc) 43.01±1.88(bc) 748.11±1.79(abc) 56.32±2.04 Na CMC 
76.31±2.61(abc) 56.56±3.26(bc) 621.33±16.66(bc) 57.91±1.66 Carpobol 940 
83.76±3.79 53.98±3.66 637.44±24.56(def) 58.49±1.48 Ca+2 Cross linking type 
86.60±3.35 46.95±2.55 698.33±21.88(de) 56.42±2.15 Ba+2 
88.61±2.12 50.27±2.8 675.77±27.80(df) 58.51±1.61 Zn+2 
87.11±2.6 55.52±3.24 620.33±23.17(ghi) 59.74±1.65 0.5 Chitosan concentration 
85.05±3.7 50.06±2.23 682.22±21.86(gh) 57.61±1.19 1 
86.80±3.2 45.62±2.5 709.00±23.76(gi) 56.07±2.18 1.5 
Each value represents the mean of each factor±standard error of the mean (SE), Statistical analysis was determined using ANOVA test followed by 
Tukey‐Kramer multiple comparisons test. aHPMC Significantly different at p<0.05, bCMC Significantly different at p<0.05, cCarpobol 940 Significantly 
different at p<0.05, Ca+2 Significantly different at p<0.05, eBa+2 Significantly different at p<0.05, fZn+2 Significantly different at p<0.05, gchitosan o.5% 
Significantly different at p<0.05, hchitosan o.5% Significantly different at p<0.05, Ichitosan o.5% Significantly different at p<0.05. 
 
 
Fig. 2: Comparative in vitro drug release of PHCL microspheres where, (a) and (b) are formula from F1 to F9 containing HPMC, (C) and (d) 
are formula from F10 to F18 containing Na CMC and (e) and (f) are formula from F19 to F27 containing Carpobol 940 
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The coefficient of variation (R2) was used as an indicator of the best 
fitting for each model. The release pattern followed Higuchi diffusion 
with R2 = 0.988; this could be attributed to the high charge density of 
chitosan at the dissolution medium resulting in the formation of the 
much stronger ionic network [22]. Formulation F20 containing; 
Carpobol 940, CaCl2, and 1% Chitosan showed the highest sustained 
release and was chosen for further investigations. 
FTIR studies 
The FTIR spectrum of pure PHCL, pure polymers, and formulations 
are shown in (fig. 3). The spectra showed band assignments at the 
same wavelength ranges indicating no interaction between the drug 
and the polymers. 
In vitro mucoadhesivity  
The selected formula (F20) exhibited good mucoadhesive property 
in the in vitro mucoadhesion test. It exhibited % mucoadhesion 70 % 
over 8 h. 
Scanning electron microsphere and morphological studies  
The morphology and surface of PHCL loaded microspheres were 
studied by SEM. A SEM photograph of the formulation (F20), a single 
microsphere taken at 45X magnification, was shown in Fig. 4, the 
drug loaded alginate microspheres were almost of spherical in shape 
and have a rough surface. Microsphere taken at 800X magnification 
was shown spherical in shape with porous. 
 
 
Fig. 3: FT-IR spectra of a) pure drug, b) Carpobol 940, c) cacl2, d) Chitosan, e) sodium alginate, f) PHCL microspheres (F20) 
 
 
Fig. 4: Scanning electron microscopy (SEM), of (PHCL) 
microspheres for selected formula (F20) at different 
magnifications 
In vivo study on human volunteers 
From the physiochemical characterizations and statistical 
analysesF20 was selected for the bioavailability compared with 
commercial tablets (Inderal® AstraZeneca). The pharmacokinetics 
parameters studied (Inderal® tablet and PHCL microspheres) show 
tmax of the prepared microspheres 4.333 h was significant (p<0.05) 
high comparing with1.75h of standard, which could be attributed to 
the delay of absorption from PHCL microspheres through release 
PHCL microsphere on control manner that increase mean residence 
time and delay Tmax.  
The plasma concentration of PHCL microspheres and Inderal® is 
shown in table 5. The mean pharmacokinetic parameters, Cmax, Tmax, 
and AUC0‐∞ is show in (table 5). The value of AUC0‐∞ is 634.66±18.91 
(ng. h/ml) and Cmax 75.635±2.33 (ng/ml) of the Inderal® while the 
PHCL microspheres have Auc0‐∞ 926.21±40.74 (ng. h/ml) and Cmax 
61.94±1.83 (ng/ml). Differences between group means were 
considered significant at p<0.05. 
Kharshoum et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 5, 311-317 
 
317 
Table 5: Pharmacokinetics parameters of Inderal® tablets and selected PHCL microsphere 
Pharmacokinetic parameters Formula  
Inderal® tablet Microspheres (F20) 
Cmax (ng/ml) 75.635±2.33 61.94±1.83a 
Tmax(h) 1.75±0.11 4.33±0.33a 
AUC0‐24(ng. h/ml) 634.93±18.98 920.26±38.93a 
Auc0‐∞(ng. h/ml) 634.66±18.91 926.21±40.74a 
%Relative Bioavailability 144.93% 
t½(h) 6.5±0.5 7.99±0.28a 
MRT0‐24(h) 8.80±0.39 13.24±0.22a 
MRT0‐∞(h) 8.79±0.39 13.37±0.192a 
Each value represents the mean of 6 human±standard error of the mean. Statistical analysis was determined using by T test followed by Tukey‐
Kramer multiple comparisons test. 
 
 
Fig. 5: Plasma concentration of PHCL following the oral 
administration of 40 mg of Inderal® tablets and PHCL 
microspheres equivalent to 40 mg to human volunteers 
 
CONCLUSION 
This study reveals that the sustained release of PHCL can be successfully 
achieved by ionotropic gelation technique using sodium alginate as a 
polymer. Prepared microspheres shown higher drug entrapment 
efficiency and prolonged release characteristics. PHCL from 
microspheres was influenced by different alginate concentrations. F20 
was estimated as best formulation because this formulation drug release 
was observed that drug was released in a controlled manner. 
CONFLICT OF INTERESTS  
Declared none 
REFERENCES 
1. RamaRao P, Reddy MN, Ramakrishna S, Diwan PV. Comparative 
in vivo evaluation of propranolol hydrochloride after oral and 
transdermal administration in rabbits. Eur J Pharm Biopharm 
2003;56:81‐5. 
2. Nethaji R, Shareef S, Palanivelu M, Surendiran SN, Ganesan B. 
Formulation and evaluation of propranolol hydrochloride 
microspheres by ionic gelation technique. Int J Pharm Chem 
Biol Sci 2015;5:407‐16. 
3. Yadav A. Formulation development and characterization of 
propranolol hydrochloride micro balloons for gastro retentive 
floating drug delivery. Afr J Pharm Pharmacol 2011;5:1801‐10. 
4.  Shivhare UD, Singare SS, Mathur VB. Formulation and 
evaluation of microspheres for immediate and sustained 
release of different drugs using the same polymer. Int J Pharm 
Dev Technol 2014;4:1‐7. 
5. Das MK, Senapati PC. Evaluation of furosemide‐loaded alginate 
microspheres prepared by ionotropic external gelation 
technique. Acta Pol Pharm 2007;64:253‐62. 
6. Yurdasiper A, Sevgi F. An overview of modified release 
chitosan, alginate and eudragit RS microparticles. J Chem 
Pharm 2010;2:704‐21. 
7. El‐rasoul SA, Ahmed MM. Chitosan polymer as a coat of calcium 
alginate microcapsules loaded by the non‐steroidal anti‐
inflammatory drug. Bull Pharm Sci 2010;33:179‐86. 
8. Khanam N, Alam MI, Sachan AK, Gangwar SS. Fabrication and 
evaluation of propranolol hydrochloride loaded microspheres 
by ionic gelation technique. Der Pharm Lett 2012;4:815‐20. 
9. Chaturvedi S, Sharma PK, Visht S, Tyagi S. Comparison of 
emulsification and Ionic gelation method of preparation of 
mucoadhesive microsphere. Pharm J 2012;1:1‐10. 
10. Prabhudesai GP, Gude R. Fabrication and characterization of 
the gastroretentive mucoadhesive microparticulate system of 
pioglitazone hydrochloride for sustained delivery. Int Res J 
Pharm 2013;4:57‐63. 
11. Yaddalapudi S, Palla G. Formulation, and evaluation of 
metformin hydrochloride sustained released microspheres. J 
Comprehensive Pharm 2014;1:136‐41. 
12. Mortazavi SA, Aboofazeli R. An investigation into the effect of 
carbopols on the release of propranolol HCl from tablet 
matrices. Iran J Pharm 2003;2:23‐7. 
13. Siahi‐Shadbad MR, Asare‐Addo K, Azizian K, Hassanzadeh D, 
Nokhodchi A. Release behavior of propranolol HCl from 
hydrophilic matrix tablets containing psyllium powder in 
combination with hydrophilic polymers. AAPS PharmSciTech 
2011;12:1176‐82. 
14. Yadav A, Jain DK. Formulation and evaluation of mucoadhesive 
microspheres of propranolol hydrochloride for sustained drug 
delivery. Asian J Pharm Med Sci 2011;1:1‐8. 
15. Sathali AAH, Varun J. Formulation, development and in vitro 
evaluation of candesartan cilexetil mucoadhesive microbeads. 
Int J Curr Pharm Res 2012;4:109‐18. 
16. Rekhi GS, Jambhekar SS, Souney PF, William DS. A fluorimetric 
liquid chromatographic method for the determination of 
propranolol in human serum/plasma. J Pharm Biomed 
1995;13:1449‐505. 
17. Yamaoka K, Nakagawa T, Uno T. Application of akaike’s 
information criterion(AIC) in the evaluation of linear 
pharmacokinetic equations. J Pharmacokinet Biopharm 
1976;6:165‐75. 
18. Lee KY, Mooney DJ. Alginate: properties and biomedical 
applications. Prog Polym Sci 2012;37:106‐26. 
19. Anal WF, Stevens AK. Chitosan‐alginate multilayer beads for 
controlled release of ampicillin. Int J Pharm 2005;290:45‐54. 
20. Abou el Ela AF, Hassan MA, El‐Maraghy DA. Ketorolac 
tromethamine floating beads for oral application: 
characterization and in vitro/in vivo evaluation. Saudi Pharm J 
2014;22:349‐59. 
21. Hemalatha C, Vasavi G, kumar C, Sriram N. Formulation and 
development of gliclazide microspheres for pharmaceutical 
evaluations. Int J Adv Pharm 2014;4:83‐92. 
22. Saleem MA, Azharuddin SM, Ali S, Patil CC. Studies on different 
chitosan polyelectrolyte complex hydrogels. Int J Pharm Pharm 
Sci 2010;2:2‐5. 
 
